Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
27.06
-0.46 (-1.67%)
At close: Apr 28, 2026, 4:00 PM EDT
27.00
-0.06 (-0.22%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Assembly Biosciences Market Cap
Assembly Biosciences has a market cap or net worth of $429.10 million as of April 28, 2026. Its market cap has increased by 530.10% in one year.
Market Cap
429.10M
Enterprise Value
183.62M
1-Year Change
530.10%
Ranking
Category
Stock Price
$27.06
Market Cap Chart
Since December 17, 2010, Assembly Biosciences's market cap has increased from $40.20M to $429.10M, an increase of 967.41%. That is a compound annual growth rate of 16.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 428.30M | -20.38% |
| Dec 31, 2025 | 537.90M | 436.29% |
| Dec 31, 2024 | 100.30M | 86.09% |
| Dec 29, 2023 | 53.90M | -14.98% |
| Dec 30, 2022 | 63.40M | -43.14% |
| Dec 31, 2021 | 111.50M | -44.19% |
| Dec 31, 2020 | 199.80M | -62.51% |
| Dec 31, 2019 | 532.90M | -7.48% |
| Dec 31, 2018 | 576.00M | -26.83% |
| Dec 29, 2017 | 787.20M | 276.11% |
| Dec 30, 2016 | 209.30M | 61.75% |
| Dec 31, 2015 | 129.40M | 54.60% |
| Dec 31, 2014 | 83.70M | 5.02% |
| Dec 31, 2013 | 79.70M | 185.66% |
| Dec 31, 2012 | 27.90M | -71.93% |
| Dec 30, 2011 | 99.40M | 135.55% |
| Dec 31, 2010 | 42.20M | 4.98% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| REGENXBIO | 448.55M |
| Aura Biosciences | 446.83M |
| Atea Pharmaceuticals | 444.57M |
| Climb Bio | 442.34M |
| Prelude Therapeutics | 441.43M |
| Eupraxia Pharmaceuticals | 439.33M |
| Lexeo Therapeutics | 430.45M |
| Neurogene | 428.65M |